aTyr Pharma Statistics

Total Valuation

aTyr Pharma has a market cap or net worth of $268.35 million. The enterprise value is $212.62 million.

Market Cap	268.35M
Enterprise Value	212.62M

Important Dates

The last earnings date was Thursday, March 13, 2025, after market close.

Earnings Date	Mar 13, 2025
Ex-Dividend Date	n/a

Share Statistics

aTyr Pharma has 88.86 million shares outstanding. The number of shares has increased by 38.53% in one year.

Current Share Class	88.86M
Shares Outstanding	88.86M
Shares Change (YoY)	+38.53%
Shares Change (QoQ)	+9.13%
Owned by Insiders (%)	2.26%
Owned by Institutions (%)	57.17%
Float	81.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1,155.16
Forward PS	n/a
PB Ratio	3.76
P/TBV Ratio	3.88
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	904.77
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.48, with a Debt / Equity ratio of 0.19.

Current Ratio	5.48
Quick Ratio	4.93
Debt / Equity	0.19
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -79.88% and return on invested capital (ROIC) is -44.99%.

Return on Equity (ROE)	-79.88%
Return on Assets (ROA)	-39.03%
Return on Invested Capital (ROIC)	-44.99%
Return on Capital Employed (ROCE)	-82.96%
Revenue Per Employee	$3,983
Profits Per Employee	-$1.09M
Employee Count	59
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +54.87% in the last 52 weeks. The beta is 0.99, so aTyr Pharma's price volatility has been similar to the market average.

Beta (5Y)	0.99
52-Week Price Change	+54.87%
50-Day Moving Average	3.64
200-Day Moving Average	2.74
Relative Strength Index (RSI)	36.93
Average Volume (20 Days)	1,702,374

Short Selling Information

The latest short interest is 6.92 million, so 7.79% of the outstanding shares have been sold short.

Short Interest	6.92M
Short Previous Month	5.26M
Short % of Shares Out	7.79%
Short % of Float	8.44%
Short Ratio (days to cover)	1.47

Income Statement

In the last 12 months, aTyr Pharma had revenue of $235,000 and -$64.02 million in losses. Loss per share was -$0.86.

Revenue	235,000
Gross Profit	-54.14M
Operating Income	-67.91M
Pretax Income	-53.93M
Net Income	-64.02M
EBITDA	-67.21M
EBIT	-67.91M
Loss Per Share	-$0.86

Full Income Statement

Balance Sheet

The company has $72.13 million in cash and $13.28 million in debt, giving a net cash position of $58.84 million or $0.66 per share.

Cash & Cash Equivalents	72.13M
Total Debt	13.28M
Net Cash	58.84M
Net Cash Per Share	$0.66
Equity (Book Value)	69.83M
Book Value Per Share	0.83
Working Capital	66.99M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$69.12 million and capital expenditures -$65,000, giving a free cash flow of -$69.18 million.

Operating Cash Flow	-69.12M
Capital Expenditures	-65,000
Free Cash Flow	-69.18M
FCF Per Share	-$0.78

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-28,899.57%
Pretax Margin	-27,243.40%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

aTyr Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-38.53%
Shareholder Yield	-38.53%
Earnings Yield	-23.58%
FCF Yield	-25.49%

Analyst Forecast

The average price target for aTyr Pharma is $18.60, which is 515.89% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$18.60
Price Target Difference	515.89%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on July 1, 2019. It was a reverse split with a ratio of 0.0714285:1.

Last Split Date	Jul 1, 2019
Split Type	Reverse
Split Ratio	0.0714285:1

Scores

aTyr Pharma has an Altman Z-Score of -5.82. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.82
Piotroski F-Score	n/a